APA (7th ed.) Citation

Mathew, B., Suresh, J., & Vinod, D. (2013). Antitumour activity of 5-[(2 E)-1-(1 H-benzimidazol-2-yl)-3-substituted phenylprop-2-en-1-ylidene] pyrimidine-2,4,6(1 H,3 H,5 H)-triones against Dalton's ascitic lymphoma in mice. Medicinal Chemistry Research, 22(8), 3911. https://doi.org/10.1007/s00044-012-0407-1

Chicago Style (17th ed.) Citation

Mathew, Bijo, Jerad Suresh, and Devaraji Vinod. "Antitumour Activity of 5-[(2 E)-1-(1 H-benzimidazol-2-yl)-3-substituted Phenylprop-2-en-1-ylidene] Pyrimidine-2,4,6(1 H,3 H,5 H)-triones Against Dalton's Ascitic Lymphoma in Mice." Medicinal Chemistry Research 22, no. 8 (2013): 3911. https://doi.org/10.1007/s00044-012-0407-1.

MLA (9th ed.) Citation

Mathew, Bijo, et al. "Antitumour Activity of 5-[(2 E)-1-(1 H-benzimidazol-2-yl)-3-substituted Phenylprop-2-en-1-ylidene] Pyrimidine-2,4,6(1 H,3 H,5 H)-triones Against Dalton's Ascitic Lymphoma in Mice." Medicinal Chemistry Research, vol. 22, no. 8, 2013, p. 3911, https://doi.org/10.1007/s00044-012-0407-1.